thiotepa has been researched along with Teratoma in 7 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Teratoma: A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment for malignant embryonal brain tumors in young children usually employs cycles of standardly dosed cisplatinum followed by high-dose carboplatinum-containing conditioning with single or tandem autologous stem cell rescue (HDC-ASCR)." | 1.56 | Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation. ( Almutereen, M; Elborai, Y; Hafez, H; Lee, MA; Lehmann, L; Maher, OM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Elborai, Y | 1 |
| Almutereen, M | 1 |
| Maher, OM | 1 |
| Hafez, H | 1 |
| Lee, MA | 1 |
| Lehmann, L | 1 |
| Fidani, P | 1 |
| De Ioris, MA | 1 |
| Serra, A | 1 |
| De Sio, L | 1 |
| Ilari, I | 1 |
| Cozza, R | 1 |
| Boldrini, R | 1 |
| Milano, GM | 1 |
| Garrè, ML | 1 |
| Donfrancesco, A | 1 |
| Kotova, DG | 1 |
| Vinokurov, VL | 1 |
| Mardakhiashvili, ShI | 2 |
| Furnari, S | 1 |
| Pavone-Macaluso, M | 1 |
| Veroux, G | 1 |
| Mattea, E | 1 |
| Frick, HC | 1 |
1 trial available for thiotepa and Teratoma
| Article | Year |
|---|---|
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschoo | 2009 |
6 other studies available for thiotepa and Teratoma
| Article | Year |
|---|---|
Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Ca | 2020 |
[Chemotherapy of patients with recurring malignant tumors of the ovaries].
Topics: Adult; Aged; Alkylating Agents; Cyclophosphamide; Cystadenocarcinoma; Drug Evaluation; Female; Granu | 1975 |
[On the prevention of postoperative recurrences in cancer of the ovaries].
Topics: Adult; Cyclophosphamide; Cystadenoma; Dysgerminoma; Female; Granulosa Cell Tumor; Humans; Middle Age | 1968 |
Cancer chemotherapy in urology.
Topics: Adenocarcinoma; Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Chlorambucil; Cobal | 1971 |
[Comparative evaluation of methods of treatment of early stages of malignant ovarian neoplasms].
Topics: Adult; Cyclophosphamide; Cystadenoma; Dysgerminoma; Female; Humans; Melphalan; Middle Aged; Ovarian | 1968 |
Over-all evaluation of chemotherapy for ovarian cancer.
Topics: Adenocarcinoma, Papillary; Adolescent; Adult; Alkylating Agents; Antineoplastic Agents; Female; Huma | 1969 |